Tutti gli studi
ReclutamentoOSSERVAZIONALE

Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis

The CF-Tracker study aims to understand what causes 'exacerbations' – or flare-ups – in people with cystic fibrosis (CF). These are times when CF symptoms worsen, often needing antibiotics. The study will follow adults with CF for 12 months, collecting health information and samples to learn more. A smaller group will have extra clinic visits and tests. There's also a pilot study for children with CF, and healthy volunteers will provide samples as a comparison. The findings from this study could help researchers develop new ways to prevent these flare-ups, ultimately improving the health and well-being of people living with CF. It's a big step towards better understanding and managing CF.

A colpo d'occhio

Stato
Reclutamento
Sponsor
Alexander Horsley
Obiettivo di iscrizione
300
Inizio
16 May 2025
Completamento stimato
31 Dec 2029

Di cosa tratta questo studio?

The CF-Tracker study is a really important project looking into cystic fibrosis (CF) and those frustrating times when symptoms suddenly get worse, often called 'exacerbations' or 'flare-ups'. If you have CF, you'll know these flare-ups can mean more coughing, more phlegm, and feeling more breathless, often leading to a course of antibiotics, either by mouth or through a drip. This study wants to find out exactly what triggers these flare-ups so we can work out better ways to prevent them from happening in the future.

The researchers will follow people with CF for a year, gathering information about their health and collecting different types of samples. This 'observational' study just means they'll be watching and collecting data, not giving new treatments. There are two main groups for adults: Group A, with 200 participants, who will mostly provide samples and information from home. Group B, with 100 participants, will do something similar but will also have extra visits to a CF clinic and, if they become unwell, may be asked to come in for samples before they start antibiotics.

There's also a small pilot study for children with CF (aged 5-16) to see if this type of research works well for them. In addition, some healthy volunteers will provide samples once, to give the researchers something to compare against. The information gathered from CF-Tracker is a key part of a bigger research effort, aiming to create better ways to prevent flare-ups and improve the lives of people with CF. This study is funded by the Cystic Fibrosis Trust, showing how important it is.

Punti chiave

  • Aims to understand why CF flare-ups happen.
  • Mainly for adults with CF, with a pilot for children.
  • Involves providing health information and various samples over 12 months.
  • Does not change your current CF treatment.
  • Findings could help prevent future CF flare-ups.
  • Participation includes home-based and/or clinic-based activities.

Chi può essere idoneo?

This study is mainly looking for adult volunteers with cystic fibrosis (CF), aged 16 or older, who receive their care at a UK adult CF clinic. To be included, you would need to have had at least one flare-up in your CF lung disease in the last 12 months that required antibiotics. You also need to be able to understand the study information and be happy to provide samples from home.

If you're interested in joining Group B, which involves more clinic visits, you'd need to be able to attend one of five specific CF centres: Manchester, Leeds, Newcastle, Cardiff, or Liverpool. If you're at the Manchester clinic and interested in extra home monitoring, you'll need home internet and be willing to have devices set up in your home.

There's also a small number of places for children with CF, aged 5-16, attending a paediatric clinic at one of the main study centres. Like adults, they would need a confirmed CF diagnosis and to have had a flare-up in the past. Parents or guardians would need to understand and agree for their child to take part.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Do I have a confirmed diagnosis of cystic fibrosis?
  2. Am I 16 years old or older? (Or 5-16 for the children's pilot)
  3. Have I had at least one CF lung flare-up needing antibiotics in the last year?
  4. Am I able to understand the study information and collect samples from home?
  5. If interested in Group B, can I attend one of the five main study clinics?
  6. If at Manchester Group B and interested, do I have home internet for monitoring?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

If you join Group A, you'll have one visit to your clinic at the very beginning of the study. During this visit, you'll provide some general health information, have some lung function tests, and give samples like blood, saliva, and urine. You'll then be given kits to collect samples at home every two weeks for the first six months. There will also be extra kits to use if you have a flare-up. You'll complete questionnaires and use a study app called "Watson" to help you remember when to send samples.

If you join Group B, you'll do everything in Group A, but you'll also have extra visits to your clinic at 1 month and 6 months. If you start to feel unwell, you might be asked to come in for an extra unplanned visit to provide samples before you start any antibiotics. If you're in Group B at the Manchester clinic, you might also have the option to take part in additional home monitoring for air quality and sleep for 12 months.

The study will last for 12 months for all participants. Your involvement doesn't change your usual CF care or medication. For children in the pilot study, the involvement would be similar to Group A but adapted for younger participants. There are also specific opportunities for healthy volunteers to provide samples just once.

Rischi e benefici potenziali

Taking part in a study like this helps researchers learn more about cystic fibrosis, which could lead to better ways to prevent flare-ups for everyone with CF in the future. While you won't personally receive a new treatment, you'll be contributing valuable information that could make a real difference. The main risks involve the time commitment for providing samples and attending visits, and the minor discomfort from giving blood or other samples. There's no major risk associated with an observational study. You are free to withdraw from the study at any time, for any reason, without it affecting your usual CF care.

Locations (18)

  • Manchester Adult Cystic Fibrosis Centre
    Codice postale verificato
    Manchester, Regno Unito· Reclutamento
  • Birmingham Heartlands Hospital
    Codice postale verificato
    Birmingham, Regno Unito· Non ancora in fase di reclutamento
  • Blackpool Teaching Hospitals
    Codice postale verificato
    Blackpool, United Kingdom· Non ancora in fase di reclutamento
  • Medical Research Unit, Bristol Royal Infirmary
    Codice postale verificato
    Bristol, Regno Unito· Non ancora in fase di reclutamento
  • Cardiff and Vale University Health Board
    Codice postale verificato
    Cardiff, Regno Unito· Reclutamento
  • Royal Devon and Exeter Hospital (Wonford)
    Codice postale verificato
    Exeter, Regno Unito· Reclutamento
  • NHS Greater Glasgow e Clyde
    Codice postale verificato
    Glasgow, Regno Unito· Reclutamento
  • Leeds Adult CF Centre
    Codice postale verificato
    Leeds, Regno Unito· Reclutamento
  • Liverpool Heart & Chest Hospital
    Codice postale verificato
    Liverpool, Regno Unito· Reclutamento
  • Chest Unit Reception, King's College Hospital
    Codice postale verificato
    Londra, Regno Unito· Non ancora in fase di reclutamento
  • Royal Brompton Hospital, Department of Cystic Fibrosis (Adult)
    Codice postale verificato
    Londra, Regno Unito· Non ancora in fase di reclutamento
  • Newcastle Adult CF Centre
    Codice postale verificato
    Newcastle upon Tyne, Regno Unito· Non ancora in fase di reclutamento

Domande comuni

What is an 'exacerbation' in CF?

An exacerbation, or flare-up, is when CF symptoms like cough, phlegm, and breathlessness get worse, often needing antibiotics.

Per quanto tempo sarò coinvolto nello studio?

The study will last for 12 months for all participants, though your direct involvement, like home sampling, might be for a shorter period.

Will taking part change my usual CF treatment?

No, this is an observational study, meaning it won't change your regular care or the medications you take for your CF.

Do I need to live near one of the study centres?

If you're in Group A, you don't need to. If you're in Group B, or the children's pilot, you'd need to be able to attend one of the five specific CF centres (Manchester, Cardiff, Newcastle, Leeds, Liverpool).

Chi sta finanziando questa ricerca?

The study is funded by the Cystic Fibrosis Trust, a leading charity supporting people with CF.

Come saperne di più

Alexander Horsley, MA MBChB MRCP PhD FERS

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Interessato a partecipare?

Registrati per ricevere aggiornamenti

Condividi i tuoi dettagli e il team di ricerca per "Identifying the Causes and Risk Factors of Pulmonary Exacerb…" ti contatterà se potresti essere idoneo. Parla sempre con il tuo medico prima di accettare di partecipare.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.